Ticker: XBI CUSIP: 78464A870 Class: S&P BIOTECH
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 12,592,500 | $1,535,404 | — | — |
| Q3 2025 | 13,825,000 | $1,385,265 | — | — |
| Q2 2025 | 12,136,000 | $1,006,438 | — | — |
| Q1 2025 | 8,486,000 | $688,215 | — | — |
| Q4 2024 | 5,165,000 | $465,160 | — | — |
| Q3 2024 | 9,229,000 | $911,825 | — | — |
| Q2 2024 | 3,091,000 | $286,567 | — | — |
| Q1 2024 | 3,136,000 | $297,575 | — | — |
| Q4 2023 | 2,406,000 | $214,832 | — | — |
| Q3 2023 | 1,771,000 | $129,318 | — | — |
| Q2 2023 | 871,000 | $72,467 | — | — |
| Q1 2023 | 871,000 | $66,379 | — | — |
| Q4 2022 | 1,705,000 | $141,515 | — | — |
| Q3 2022 | 770,000 | $61,076 | — | — |
| Q2 2022 | 770,000 | $57,188 | — | — |
| Q1 2022 | 770,000 | $69,208 | — | — |
| Q4 2021 | 5,305,000 | $593,948 | — | — |
| Q3 2021 | 4,905,000 | $616,608 | — | — |
| Q2 2021 | 3,634,000 | $492,044 | — | — |
| Q1 2021 | 9,604,000 | $1,302,783 | — | — |
| Q4 2020 | 14,334,000 | $2,017,941 | — | — |
| Q3 2020 | 2,334,000 | $260,078 | — | — |
| Q2 2020 | 2,334,000 | $261,291 | — | — |
| Q1 2020 | 2,334,000 | $180,745 | — | — |
| Q4 2019 | 4,684,000 | $445,495 | — | — |